全球寵物腫瘤藥物市場：市場規模、療法、給藥途徑、生物類型、應用、行業分析報告、區域展望、增長潛力、價格趨勢、競爭性市場份額和預測，2023-2032 年

由於寵物護理成本激增，全球寵物抗癌藥物市場預計到 2032 年將顯著增長。

此外，動物主人對動物健康和福利的認識不斷提高，進一步推動了該行業的發展。

由於淋巴瘤和黑色素瘤等癌症在寵物中的發病率呈上升趨勢，因此全球對寵物癌症治療藥物的需求正在擴大。 隨著寵物主人越來越多地在動物保健上花錢，對寵物癌症治療的需求也越來越大，尤其是在發達國家。

此外，行業參與者正在通過戰略合作夥伴關係和協作來鞏固其市場地位。 例如，2021 年 6 月，勃林格殷格翰和 WEHI 宣布合作，通過協調的蛋白水解機制發現和設計抗癌療法。 這種夥伴關係使我們能夠結合我們在生物學、治療靶點、蛋白水解和藥物發現方面的知識，專注於致癌蛋白。

寵物抗癌藥物市場根據治療、給藥途徑、物種、應用和地理區域進行細分。

基於治療，到 2032 年，靶向治療領域的市場估值預計將超過 1.63 億美元。 個性化醫療的流行和當前的進步是支持該領域發展的主要因素。 此外，寵物腫瘤的研發能力有望提升各公司的潛力。 預計這些發展將顯著加速市場擴張。

通過應用，黑色素瘤面積有望在研究期間顯著增長。 寵物黑色素瘤病例激增已成為推動業務增長的主要渲染因素。 根據美國國家生物技術信息中心 (NCBI) 的數據，犬類黑色素瘤在 2017 年佔犬類所有口腔癌的 14.4% 至 45.5%，被認為是最常見的口腔惡性腫瘤。

由於寵物癌症患病率上升和寵物護理成本飆升，預計到 2032 年亞太地區寵物癌症治療市場的價值將超過 4700 萬美元。. 據2020年中國寵物行業統計，全國寵物犬存欄量超過5222萬隻。 腫瘤也是寵物犬的常見病，患病率為0.282%～1.701%。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章：寵物抗癌藥物的行業洞察

• 2018-2032 年行業形勢變化
• 影響行業的因素
  • 司機
    • 寵物癌症增加
    • 提高寵物主人對寵物疾病的認識
    • 寵物護理支出增加
    • 寵物癌症治療藥物的技術進步，包括癌症免疫療法
    • 高度未滿足的醫療需求和巨大的潛力
  • 行業潛在的風險和挑戰
    • 與寵物抗癌藥物相關的副作用
    • 獸醫腫瘤學家短缺
• 增長分析
  • 通過治療
  • 按給藥途徑
  • 按事件
  • 通過申請
• COVID-19 影響分析
• 產品管道分析
• 監管狀況
  • 美國
  • 歐盟
  • 巴西
  • 澳大利亞
  • 印度
• 差距分析
• 波特分析
• PESTLE 分析

第 4 章競爭格局，2021 年

• 介紹
• 2021 年公司矩陣分析
• 戰略儀表板，2021 年

第 5 章寵物抗癌藥物市場：按治療分類

• 主要治療趨勢
• 化療
• 免疫療法
• 靶向治療
• 聯合療法

第 6 章寵物抗癌藥市場：按給藥途徑分類

• 主要給藥途徑的趨勢
• 口語
• 注射

第 7 章寵物抗癌藥物市場：按生物體分類

• 主要物種的趨勢
• 狗
• 貓

第 8 章寵物抗癌藥物市場：按應用

• 主要應用趨勢
• 淋巴瘤
• 肥大細胞瘤
• 黑色素瘤
• 乳腺癌/鱗狀細胞癌
• 其他

第 9 章寵物癌症治療市場：按地區

• 主要區域趨勢
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 意大利
  • 瑞典
  • 瑞士
  • 荷蘭
  • 奧地利
  • 波蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 菲律賓
  • 新西蘭
• 拉丁美洲
  • 巴西
  • 墨西哥

第十章公司簡介

• Zoetis, Inc.
• Elanco Animal Health
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals
• AB Science
• Qbiotics
• NovaVive, Inc.
• ELIAS Animal Health

Global Pet Cancer Therapeutics Market is speculated to grow considerably through 2032 owing to the surging pet care expenses. Moreover, the rising awareness among pet owners regarding the health and well-being of animals has further bolstered industry growth.

The demand for pet cancer therapies is expanding globally due to the rising prevalence of pet cancers including lymphoma and melanoma, among many others. Also, the growing propensity of pet owners to spend money on animal healthcare is raising the need for cancer treatments for pets, particularly in industrialized nations.

In addition, the leading industry players are seeking to strengthen their position in the market through strategic partnership and collaboration. For instance, in June 2021, Boehringer Ingelheim and WEHI announced their partnership to explore and design anti-cancer therapies via a tailored protein degradation mechanism. The alliance enabled the firm to combine its knowledge of biology, therapeutic targeting, protein degradation, and drug discovery to focus on cancer-causing proteins.

The pet cancer therapeutics market has been divided in terms of therapy, route of administration, species, application, and region.

Based on therapy, the targeted therapy segment is expected to amass more than USD 163 million in market valuation by 2032. The rising use of personalized therapy and current advances are the primary drivers behind robust segmental growth. Additionally, it is anticipated that pet oncology R&D capabilities will improve the various companies' potential. Those developments are predicted to significantly accelerate market expansion.

With respect to application, the melanoma segment is set to attain sizable growth over the review period. The upsurge in melanoma cases amongst pets is the key rendering factor fueling business growth. According to the National Centers for Biotechnology Information (NCBI), canine melanoma, which made up 14.4% to 45.5% of all oral cancers in dogs in 2017, was thought to be the most common oral malignancy.

From the regional outlook, the Asia Pacific pet cancer therapeutics market is estimated to surpass over USD 47 million valuation by 2032 attributed to the increased prevalence of cancer among pets as well the skyrocketing pet care costs in the region. As per the statistics on China's pet industry in 2020, the pet dog adoption in the country has exceeded 52.22 million. Moreover, tumor has stood as a common disease in pet dog, with prevalence ranging from 0.282% to 1.701%.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Methodology
• 1.2 Market scope & definitions
• 1.3 Base estimates and working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Pet cancer therapeutics industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Therapy trends
  • 2.1.3 Route of administration trends
  • 2.1.4 Species trends
  • 2.1.5 Applications trends
  • 2.1.6 Regional trends

Chapter 3 Pet Cancer Therapeutics Industry Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of pet cancer
    • 3.2.1.2 Growing awareness among pet owners regarding pet diseases
    • 3.2.1.3 Increasing pet care expenditure
    • 3.2.1.4 Technological advancements in pet cancer therapeutics including cancer immunotherapy
    • 3.2.1.5 High medical unmet need and strong potential
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side effects associated with pet cancer therapeutics
    • 3.2.2.2 Lack of veterinary oncologists
• 3.3 Growth potential analysis
  • 3.3.1 By therapy
  • 3.3.2 By route of administration
  • 3.3.3 By species
  • 3.3.4 By application
• 3.4 COVID- 19 impact analysis
• 3.5 Product pipeline analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 European Union
  • 3.6.3 Brazil
  • 3.6.4 Australia
  • 3.6.5 India
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTLE analysis

Chapter 4 Competitive landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis, 2021
• 4.3 Strategy dashboard, 2021

Chapter 5 Pet Cancer Therapeutics Market, By Therapy

• 5.1 Key therapy trends
• 5.2 Chemotherapy
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Immunotherapy
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.4 Targeted therapy
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.5 Combination therapy
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Pet Cancer Therapeutics Market, By Route of Administration

• 6.1 Key route of administration trends
• 6.2 Oral
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Injection
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Pet Cancer Therapeutics Market, By Species

• 7.1 Key species trends
• 7.2 Dogs
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 Cats
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Pet Cancer Therapeutics Market, By Application

• 8.1 Key application trends
• 8.2 Lymphoma
  • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.3 Mast cell cancer
  • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.4 Melanoma
  • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.5 Mammary and squamous cell cancer
  • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.6 Others
  • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Pet Cancer Therapeutics Market, By Region

• 9.1 Key regional trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Sweden
  • 9.3.7 Switzerland
  • 9.3.8 The Netherlands
  • 9.3.9 Austria
  • 9.3.10 Poland
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Philippines
  • 9.4.7 New Zealand
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico

Chapter 10 Company Profiles

• 10.1 Zoetis, Inc.
• 10.2 Elanco Animal Health
• 10.3 Boehringer Ingelheim International GmbH
• 10.4 Dechra Pharmaceuticals
• 10.5 AB Science
• 10.6 Qbiotics
• 10.7 NovaVive, Inc.
• 10.8 ELIAS Animal Health

DATA TABLES

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by therapy
• TABLE 3 Market revenue, by route of administration
• TABLE 4 Market revenue, by species
• TABLE 5 Market revenue, by application
• TABLE 6 Market revenue, by region
• TABLE 7 Global pet cancer therapeutics market, 2018 - 2022 (USD Million)
• TABLE 8 Global pet cancer therapeutics market, 2023 - 2032 (USD Million)
• TABLE 9 Global pet cancer therapeutics market, by therapy, 2018 - 2022 (USD Million)
• TABLE 10 Global pet cancer therapeutics market, by therapy, 2023 - 2032 (USD Million)
• TABLE 11 Global pet cancer therapeutics market, by route of administration, 2018 - 2022 (USD Million)
• TABLE 12 Global pet cancer therapeutics market, by route of administration, 2023 - 2032 (USD Million)
• TABLE 13 Global pet cancer therapeutics market, by species, 2018 - 2022 (USD Million)
• TABLE 14 Global pet cancer therapeutics market, by species, 2023 - 2032 (USD Million)
• TABLE 15 Global pet cancer therapeutics market, by application, 2018 - 2022 (USD Million)
• TABLE 16 Global pet cancer therapeutics market, by application, 2023 - 2032 (USD Million)
• TABLE 17 Global pet cancer therapeutics market, by region, 2018 - 2022 (USD Million)
• TABLE 18 Global pet cancer therapeutics market, by region, 2023 - 2032 (USD Million)
• TABLE 19 Industry impact forces
• TABLE 20 Chemotherapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 21 Chemotherapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 22 Immunotherapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 23 Immunotherapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 24 Targeted therapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 25 Targeted therapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 26 Combined therapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 27 Combined therapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 28 Oral market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 29 Oral market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 30 Injection market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 31 Injection market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 32 Dogs market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 33 Dogs market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 34 Cats market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 35 Cats market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 36 Lymphoma market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 37 Lymphoma market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 38 Mast cell cancer market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 39 Mast cell cancer market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 40 Melanoma market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 41 Melanoma market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 42 Mammary and squamous cell cancer market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 43 Mammary and squamous cell cancer market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 44 Others market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 45 Others market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 46 North America pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 47 North America pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 48 North America pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 49 North America pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 50 North America pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 51 North America pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 52 North America pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 53 North America pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 54 North America pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 55 North America pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 56 U.S. pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 57 U.S. pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 58 U.S. pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 59 U.S. pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 60 U.S. pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 61 U.S. pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 62 U.S. pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 63 U.S. pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 64 Canada pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 65 Canada pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 66 Canada pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 67 Canada pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 68 Canada pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 69 Canada pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 70 Canada pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 71 Canada pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 72 Europe pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 73 Europe pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 74 Europe pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 75 Europe pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 76 Europe pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 77 Europe pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 78 Europe pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 79 Europe pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 80 Europe pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 81 Europe pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 82 Germany pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 83 Germany pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 84 Germany pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 85 Germany pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 86 Germany pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 87 Germany pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 88 Germany pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 89 Germany pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 90 UK pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 91 UK pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 92 UK pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 93 UK pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 94 UK pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 95 UK pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 96 UK pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 97 UK pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 98 France pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 99 France pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 100 France pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 101 France pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 102 France pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 103 France pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 104 France pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 105 France pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 106 Spain pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 107 Spain pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 108 Spain pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 109 Spain pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 110 Spain pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 111 Spain pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 112 Spain pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 113 Spain pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 114 Italy pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 115 Italy pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 116 Italy pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 117 Italy pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 118 Italy pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 119 Italy pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 120 Italy pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 121 Italy pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 122 Sweden pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 123 Sweden pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 124 Sweden pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 125 Sweden pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 126 Sweden pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 127 Sweden pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 128 Sweden pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 129 Sweden pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 130 Switzerland pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 131 Switzerland pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 132 Switzerland pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 133 Switzerland pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 134 Switzerland pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 135 Switzerland pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 136 Switzerland pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 137 Switzerland pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 138 The Netherlands pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 139 The Netherlands pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 140 The Netherlands pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 141 The Netherlands pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 142 The Netherlands pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 143 The Netherlands pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 144 The Netherlands pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 145 The Netherlands pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 146 Austria pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 147 Austria pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 148 Austria pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 149 Austria pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 150 Austria pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 151 Austria pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 152 Austria pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 153 Austria pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 154 Poland pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 155 Poland pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 156 Poland pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 157 Poland pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 158 Poland pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 159 Poland pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 160 Poland pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 161 Poland pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 162 Asia Pacific pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 163 Asia Pacific pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 164 Asia Pacific pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 165 Asia Pacific pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 166 Asia Pacific pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 167 Asia Pacific pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 168 Asia Pacific pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 169 Asia Pacific pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 170 Asia Pacific pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 171 Asia Pacific pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 172 China pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 173 China pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 174 China pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 175 China pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 176 China pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 177 China pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 178 China pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 179 China pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 180 India pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 181 India pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 182 India pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 183 India pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 184 India pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 185 India pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 186 India pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 187 India pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 188 Japan pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 189 Japan pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 190 Japan pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 191 Japan pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 192 Japan pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 193 Japan pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 194 Japan pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 195 Japan pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 196 Australia pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 197 Australia pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 198 Australia pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 199 Australia pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 200 Australia pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 201 Australia pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 202 Australia pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 203 Latin America pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 204 Latin America pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 205 Latin America pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 206 Latin America pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 207 Latin America pet cancer therapeutics market, by route of administration, 2018-2022, (USD Million)
• TABLE 208 Latin America pet cancer therapeutics market, by route of administration, 2023-2032, (USD Million)
• TABLE 209 Latin America pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 210 Latin America pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 211 Latin America pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 212 Latin America pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 213 Brazil pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 214 Brazil pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 215 Brazil pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 216 Brazil pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 217 Brazil pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 218 Brazil pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 219 Brazil pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 220 Brazil pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 221 Mexico pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 222 Mexico pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 223 Mexico pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 224 Mexico pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 225 Mexico pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 226 Mexico pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 227 Mexico pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 228 Mexico pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)

Charts & Figures

• FIG. 1 GMI Report Coverage: Critical research elements
• FIG. 2 Top-down approach
• FIG. 3 Breakdown of primary participants
• FIG. 4 Pet cancer therapeutics market industry 360 degree synopsis, 2018 - 2032
• FIG. 5 Industry landscape, 2018 - 2032 (USD Million)
• FIG. 6 Growth potential analysis, by therapy
• FIG. 7 Growth potential analysis, by route of administration
• FIG. 8 Growth potential analysis, by species
• FIG. 9 Growth potential analysis, by application
• FIG. 9 Gap analysis
• FIG. 10 Porter's analysis
• FIG. 11 PESTEL analysis
• FIG. 12 Company matrix analysis, 2021
• FIG. 13 Strategy dashboard, 2021